» Articles » PMID: 33189556

The Burden of COVID-19 on Pharmacists

Overview
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2020 Nov 15
PMID 33189556
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The unprecedented changes brought about by the global coronavirus disease 2019 (COVID-19) pandemic have had important impacts on society. The pandemic has provided an opportunity to highlight the crucial role pharmacists play in the provision of health care. The critical and unique role of pharmacists in pandemics and other disasters has been highlighted in the past (severe acute respiratory syndrome and Ebola outbreaks) and more recently with reports of the contributions of pharmacists during the global COVID-19 pandemic. Many reports have documented that health care professionals are experiencing significant psychological morbidity as a result of providing essential care and services during the global COVID-19 pandemic. In these reports, pharmacists are not well represented, and, therefore, it is essential to understand the impact of COVID-19 on pharmacists across multiple practice settings. This is particularly true as the experiences of pharmacists working through previous pandemics and disasters, and the associated psychological burden, are likely to offer insights and be useful in supporting the psychological well-being of pharmacists during the global COVID-19 pandemic. Research into the effect of the global COVID-19 pandemic on pharmacists should improve the understanding of the impact and the psychological morbidity associated with their role as frontline health care professionals.

Citing Articles

Prescription for change: Unveiling burnout perspectives among pharmacy leaders.

Kiriazopoulos S, Perepelkin J, Alford H Can Pharm J (Ott). 2024; 158(2):98-109.

PMID: 39619259 PMC: 11607704. DOI: 10.1177/17151635241293785.


Pharmacy Students' Perspectives on Human Resource Management: An Examination of Knowledge and Attitudes.

Adunlin G, Broeseker A, Thigpen J, Sheaffer E, Calhoun M Pharmacy (Basel). 2024; 12(1).

PMID: 38392934 PMC: 10893198. DOI: 10.3390/pharmacy12010027.


Resources and interventions to support psychological health and wellbeing in the pharmacy workforce: Analysis and use of a health worker 'burnout' toolkit.

Mulherin K, Brandt J, Hu A, Ravinatarajan P Explor Res Clin Soc Pharm. 2023; 12:100359.

PMID: 37965247 PMC: 10641757. DOI: 10.1016/j.rcsop.2023.100359.


Sociotechnical Work System Approach to Occupational Fatigue.

Watterson T, Steege L, Mott D, Ford 2nd J, Portillo E, Chui M Jt Comm J Qual Patient Saf. 2023; 49(9):485-493.

PMID: 37407330 PMC: 10530575. DOI: 10.1016/j.jcjq.2023.05.007.


Understanding the Risk Factors and Stressors Impacting Optimal Work Practices in New Zealand Pharmacies: A S.H.E.L.L Model Analysis.

Wong L, Ram S, Scahill S Pharmacy (Basel). 2023; 11(3).

PMID: 37368416 PMC: 10302957. DOI: 10.3390/pharmacy11030090.


References
1.
Robertson E, Hershenfield K, Grace S, Stewart D . The psychosocial effects of being quarantined following exposure to SARS: a qualitative study of Toronto health care workers. Can J Psychiatry. 2004; 49(6):403-7. DOI: 10.1177/070674370404900612. View

2.
Zheng S, Yang L, Zhou P, Li H, Liu F, Zhao R . Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 2020; 17(1):1819-1824. PMC: 7102520. DOI: 10.1016/j.sapharm.2020.03.012. View

3.
Chua S, Cheung V, Cheung C, McAlonan G, Wong J, Cheung E . Psychological effects of the SARS outbreak in Hong Kong on high-risk health care workers. Can J Psychiatry. 2004; 49(6):391-3. DOI: 10.1177/070674370404900609. View

4.
Shah K, Chaudhari G, Kamrai D, Lail A, Patel R . How Essential Is to Focus on Physician's Health and Burnout in Coronavirus (COVID-19) Pandemic?. Cureus. 2020; 12(4):e7538. PMC: 7198080. DOI: 10.7759/cureus.7538. View

5.
Erku D, Belachew S, Abrha S, Sinnollareddy M, Thomas J, Steadman K . When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19. Res Social Adm Pharm. 2020; 17(1):1954-1963. PMC: 7252082. DOI: 10.1016/j.sapharm.2020.04.032. View